The Cigna Corp. Health Services business will launch a solution in 2020 for covering high cost gene therapies in which payers enroll and make monthly per member payments into a newly dedicated program that would cover the cost of gene therapy in the future if they have a member who needs treatment.
The program will be administered primarily by Cigna’s eviCore specialty medical management business, which is part of Express Scripts...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?